- Home
- INTR vs HRMY Comparison
INTR vs HRMY Comparison
Compare INTR & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTR
- HRMY
- Stock Information
- Founded
- INTR 1994
- HRMY 2017
- Country
- INTR Brazil
- HRMY United States
- Employees
- INTR N/A
- HRMY N/A
- Industry
- INTR
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- INTR
- HRMY Health Care
- Exchange
- INTR Nasdaq
- HRMY Nasdaq
- Market Cap
- INTR 2.1B
- HRMY 2.2B
- IPO Year
- INTR N/A
- HRMY 2020
- Fundamental
- Price
- INTR $5.45
- HRMY $33.71
- Analyst Decision
- INTR Strong Buy
- HRMY Strong Buy
- Analyst Count
- INTR 3
- HRMY 8
- Target Price
- INTR $7.30
- HRMY $53.75
- AVG Volume (30 Days)
- INTR 4.1M
- HRMY 731.0K
- Earning Date
- INTR 02-06-2025
- HRMY 04-29-2025
- Dividend Yield
- INTR 1.48%
- HRMY N/A
- EPS Growth
- INTR 176.00
- HRMY 17.84
- EPS
- INTR 0.33
- HRMY 2.51
- Revenue
- INTR $743,862,312.00
- HRMY $714,734,000.00
- Revenue This Year
- INTR $78.04
- HRMY $21.08
- Revenue Next Year
- INTR $17.41
- HRMY $22.48
- P/E Ratio
- INTR $16.13
- HRMY $13.37
- Revenue Growth
- INTR 43.28
- HRMY 22.80
- 52 Week Low
- INTR $3.88
- HRMY $28.14
- 52 Week High
- INTR $7.84
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- INTR 56.59
- HRMY 42.86
- Support Level
- INTR $4.90
- HRMY $31.73
- Resistance Level
- INTR $5.51
- HRMY $34.16
- Average True Range (ATR)
- INTR 0.23
- HRMY 1.78
- MACD
- INTR -0.02
- HRMY -0.33
- Stochastic Oscillator
- INTR 72.60
- HRMY 24.21
About INTR Inter & Co. Inc.
Inter & Co Inc operates as a digital bank. The company's segment includes Banking & Spending; Investments; Insurance Brokerage; and Inter Shop & Commerce Plus. It generates maximum revenue from the Banking & Spending.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.